The DOI matches its Crossref record; 110 of the 114 references it cites were found in a registry or an index.
The Dual Roles of NRF2 in Cancer
Open accessAbstract
NRF2 has been traditionally considered as a tumor suppressor because its cytoprotective functions are deemed to be the main cellular defense mechanism against exogenous and endogenous insults, including xenobiotics and oxidative stress. However, several recent studies demonstrate that hyperactivation of the NRF2 pathway creates an environment that favors the survival of normal as well as malignant cells, protecting them against oxidative stress, chemotherapeutic agents, and radiotherapy. In a rapidly advancing field, this review summarizes some of the known mechanisms by which NRF2 can exert its oncogenic functions, and describes the current status of NRF2 inhibitors, providing a clear rationale for the consideration of NRF2 as a powerful putative therapeutic target in cancer treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NRF2 is mutationally activated in 10–30% of different solid tumors including liver, lung, stomach, colon and other cancers and mutations typically disrupt the interaction between NRF2 and its E3 ligase KEAP1 (Kelch Like ECH Associated Protein 1) directly or by impeding KEAP1 co-factors CUL3 (Cullin 3) and CAND1 (Cullin Associated and Neddylation Dissociated 1) [2,5,6,7,8].”
From NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy (2021) · cites this paper as [8]
In the citing paper
“NRF2 is mutationally activated in 10–30% of different solid tumors including liver, lung, stomach, colon and other cancers and mutations typically disrupt the interaction between NRF2 and its E3 ligase KEAP1 (Kelch Like ECH Associated Protein 1) directly or by impeding KEAP1 co-factors CUL3 (Cullin 3) and CAND1 (Cullin Associated and Neddylation Dissociated 1) [2,5,6,7,8].”
From NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy (2021) · cites this paper as [8]
In the citing paper
“In this regard, mutations to NRF2 and its regulator KEAP1 have been found in cancer cells, supporting the supposition that antioxidant genes are pivotal in tumor progression59–62.”
From ROS in cancer therapy: the bright side of the moon (2020) · cites this paper as [61]
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D. L., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,161
Komatsu, M., Kurokawa, H., Waguri, S., Taguchi, K., Kobayashi, A., Ichimura, Y., Sou, Y.-S., Ueno, I., Sakamoto, A., Tong, K. I., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2021 · Cited by 2,288
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K. H., Yeo, C. J., Calhoun, E. S., et al. (2011) · Nature · doi:10.1038/nature10189 · Cited by 2,277
Kobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224
Nrf2–Keap1 defines a physiologically important stress response mechanism
Motohashi, H., & Yamamoto, M. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.09.003 · Cited by 1,725 · cited 1×
“NRF2: Tumor Suppressor or Oncogene? The main function of the transcription factor NRF2 [also known as NFE2L2, nuclear factor (erythroid-derived-2)-like 2] is to activate the cellular antioxidant response by inducing the transcription of several genes to protect cells from the effects of exogenous and endogenous insult…”
BackgroundMoi, P., Chan, K., Asunis, I., Cao, A., & Kan, Y. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9926 · Cited by 1,607
Guichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Benmaad, I., Caldéraro, J., Bioulac‐Sage, P., Letexier, M., Degos, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2256 · Cited by 1,522
Flagged first, then by citations
4 of the 114 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 637
Role of the Nrf2 Signaling Pathway in Ovarian Aging: Potential Mechanism and Protective Strategies
Gao, X., Wang, B., Huang, Y., Wu, M., Li, Y., Li, Y., Zhu, X., & Wu, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713327 · Cited by 44
Nrf2: A promising therapeutic target in bone-related diseases
Che, J., Yang, X., Jin, Z., & Xu, C. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115748 · Cited by 45
The Wnt inhibitor LGK-974 enhances radiosensitivity of HepG2 cells by modulating Nrf2 signaling
Tian, D., Shi, Y., Chen, D., Liu, Q., & Fan, F. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4042 · Cited by 43
Li, Q., Xing, S., Chen, Y., Liao, Q., Li, Q., Liu, Y., He, S., Feng, F., Chen, Y., Zhang, J., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111862 · Cited by 43
Environmental carcinogenesis and pH homeostasis: Not only a matter of dysregulated metabolism
Hardonnière, K., Laurence Therese, H. U. C., Sergent, O., Holme, J. A., & Lagadic‐Gossmann, D. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.01.001 · Cited by 46
Identification of an Unfavorable Immune Signature in Advanced Lung Tumors from Nrf2-Deficient Mice
Zhang, D., Rennhack, J. P., Andrechek, E. R., Rockwell, C. E., & Liby, K. T. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7201 · Cited by 44
MicroRNAs as regulators of VEGFA and NFE2L2 in cancer
Cuzziol, C. I., Castanhole-Nunes, M. M. U., Pavarino, É. C., & Goloni‐Bertollo, E. M. (2020) · Gene · doi:10.1016/j.gene.2020.144994 · Cited by 42
Coumarins and Gastrointestinal Cancer: A New Therapeutic Option?
Banikazemi, Z., Mirazimi, S. M. A., Dashti, F., Mazandaranian, M. R., Akbari, M., Morshedi, K., Aslanbeigi, F., Rashidian, A., Chamanara, M., Hamblin, M. R., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.752784 · Cited by 42
The Redox Paradox: Cancer’s Double-Edged Sword for Malignancy and Therapy
Ranbhise, J. S., Singh, M. K., Ju, S., Han, S., Yun, H. R., Kim, S. S., & Kang, I. (2025) · Antioxidants · doi:10.3390/antiox14101187 · Cited by 44
Bisphenol A and its substitutes regulate human B cell survival via Nrf2 expression
Jang, J., Lee, J., Yoon, Y. D., Kang, J. S., & Moon, E. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2019.113907 · Cited by 42
Lu, M., Zhang, X., Zhao, J., You, Q., & Jiang, Z. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101565 · Cited by 41
Liang, M., Wang, L., Sun, Z., Chen, X., Wang, H., Qin, L., Zhao, W., & Geng, B. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00875-7 · Cited by 44
Johnson, G. S., Li, J., Beaver, L. M., Dashwood, W. M., Sun, D., Rajendran, P., Williams, D. E., Ho, E., & Dashwood, R. H. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600769 · Cited by 40
Marampon, F., Codenotti, S., Megiorni, F., Fattore, A. D., Camero, S., Gravina, G. L., Festuccia, C., Musio, D., Felice, F. D., Nardone, V., et al. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-02851-0 · Cited by 40
Roles of NRF3 in the Hallmarks of Cancer: Proteasomal Inactivation of Tumor Suppressors
Kobayashi, A. (2020) · Cancers · doi:10.3390/cancers12092681 · Cited by 41
Genetic deletion of Nox4 enhances cancerogen-induced formation of solid tumors
Helfinger, V., von Gall, F. F., Henke, N., Kunze, M. M., Schmid, T., Rezende, F., Heidler, J., Wittig, I., Radeke, H. H., Marschall, V., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020152118 · Cited by 42
Cirone, M. (2021) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2021.1934811 · Cited by 41
Fischer, F., Grigolon, G., Benner, C., & Ristow, M. (2022) · Physiological Reviews · doi:10.1152/physrev.00017.2021 · Cited by 42
Association of nanoparticles and Nrf2 with various oxidative stress-mediated diseases
Thiruvengadam, R., Venkidasamy, B., Samynathan, R., Rajakumar, G., Thiruvengadam, M., & Kim, J. H. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110535 · Cited by 40
Immunometabolism and oxidative stress: roles and therapeutic strategies in cancer and aging
Zhou, N.-J., Bao, W.-Q., Zhang, C., Jiang, M., Liang, T.-L., Ma, G.-Y., Liu, L., Pan, H., & Li, R.-Z. (2025) · npj Aging · doi:10.1038/s41514-025-00250-z · Cited by 45
Li, S., Yang, G., Zhu, X., Cheng, L., Sun, Y., & Zhao, Z. (2017) · Oncology Reports · doi:10.3892/or.2017.5849 · Cited by 39
Haque, E., Karim, M. R., Teeli, A. S., Śmiech, M., Leszczyński, P., Winiarczyk, D., Parvanov, E. D., Atanasov, A. G., & Taniguchi, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155378 · Cited by 40
Ghosh, S., Dutta, N., Banerjee, P., Gajbhiye, R. L., SARENG, H. R., Kapse, P., Pal, S., Burdelya, L. G., Mandal, N. C., Ravichandiran, V., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.037 · Cited by 36
Role of chemopreventive phytochemicals in NRF2-mediated redox homeostasis in humans
Chun, K., Raut, P. K., Kim, D., & Surh, Y. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.06.031 · Cited by 37
Targeting the AMPK/Nrf2 Pathway: A Novel Therapeutic Approach for Acute Lung Injury
Huang, Q., Ren, Y., Yuan, P., Huang, M., Liu, G., Shi, Y., Jia, G., & Chen, M. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s467882 · Cited by 41
Orrù, C., Szydlowska, M., Taguchi, K., Zavattari, P., Perra, A., Yamamoto, M. P., & Columbano, A. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.010 · Cited by 39
Self-citationJang, C. H., Moon, N., Lee, J., Kwon, M. J., Oh, J., & Kim, J. (2022) · Antioxidants · doi:10.3390/antiox11040626 · Cited by 36
Smoker extracellular vesicles influence status of human bronchial epithelial cells
Héliot, A., Landkocz, Y., Saint-Georges, F. R., Gosset, P., Billet, S., Shirali, P., Courcot, D., & Martin, P. J. (2016) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2016.12.010 · Cited by 39
ATDC binds to KEAP1 to drive NRF2-mediated tumorigenesis and chemoresistance in pancreatic cancerPreprint
Purohit, V., Wang, L., Yang, H., Li, J., Ney, G. M., Gumkowski, E. R., Vaidya, A. J., Wang, A., Bhardwaj, A., Zhao, E., et al. (2021) · Genes & Development · doi:10.1101/gad.344184.120 · Cited by 39
Microbiota, Oxidative Stress, and Skin Cancer: An Unexpected Triangle
Azzimonti, B., Ballacchino, C., Zanetta, P., Cucci, M. A., Monge, C., Grattarola, M., Dianzani, C., Barrera, G., & Pizzimenti, S. (2023) · Antioxidants · doi:10.3390/antiox12030546 · Cited by 41
Dithiolethiones: A Privileged Pharmacophore for Anticancer Therapy and Chemoprevention
Ansari, M. I., Khan, M. M., Saquib, M., Khatoon, S., & Hussain, M. K. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0281 · Cited by 37
Mylka, V., Deckers, J., Ratman, D., Cauwer, L. D., Thommis, J., Rycke, R. M. D., Impens, F., Libert, C., Tavernier, J. H., Berghe, W. V., et al. (2018) · Autophagy · doi:10.1080/15548627.2018.1495681 · Cited by 35
Zhang, X., Li, T., Gong, E. S., & Liu, R. H. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c03202 · Cited by 37
Dietary Flavonoids in p53—Mediated Immune Dysfunctions Linking to Cancer Prevention
Siddiqui, S. S., Rahman, S., Rupasinghe, H. P. V., & Vazhappilly, C. G. (2020) · Biomedicines · doi:10.3390/biomedicines8080286 · Cited by 36
Wdr1 and cofilin are necessary mediators of immune-cell-specific apoptosis triggered by Tecfidera
Poganik, J. R., Huang, K., Parvez, S., Zhao, Y., Raja, S., Long, M. J. C., & Aye, Y. (2021) · Nature Communications · doi:10.1038/s41467-021-25466-x · Cited by 35
Temozolomide Resistance in Glioblastoma by NRF2: Protecting the Evil
Lima, K. A., Osawa, I. Y. A., Ramalho, M. C. C., de Souza, I., Guedes, C. B., Filho, C. H. D. D. S., Monteiro, L. K. S., Latância, M. T., & Rocha, C. R. R. (2023) · Biomedicines · doi:10.3390/biomedicines11041081 · Cited by 41
The nuclear factor erythroid 2-related factor 2/p53 axis in breast cancer
Fakheri, H., Sajadi, M. A., Afrashteh, A., Ma, W., Xia, L., & Valilo, M. (2023) · Biochemia Medica · doi:10.11613/bm.2023.030504 · Cited by 40
NRF2 in neurodegenerative diseases
Cuadrado, A. (2016) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2016.09.004 · Cited by 36
New insights into organ-specific oxidative stress mechanisms using a novel biosensor zebrafish
Mourabit, S., Fitzgerald, J. A., Ellis, R. P., Takesono, A., Porteus, C. S., Trznadel, M., Metz, J., Winter, M. J., Kudoh, T., & Tyler, C. R. (2019) · Environment International · doi:10.1016/j.envint.2019.105138 · Cited by 36
Cai, L., Jin, X., Zhang, J., Li, L., & Zhao, J. (2020) · Aging · doi:10.18632/aging.103777 · Cited by 36
Zhang, S., Zhang, J., Evert, K., Li, X., Pin, L., Kiss, A., Schaff, Z., Ament, C. E., Zhang, Y., Serra, M., et al. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.03.011 · Cited by 35
Fetoni, A. R., Paciello, F., & Troiani, D. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0183 · Cited by 37
Dash, S., Aydın, Y., & Wu, T. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.07.015 · Cited by 36
The KEAP1/NRF2 Signaling Pathway in Keratinization
Ishitsuka, Y., Ogawa, T., & Roop, D. R. (2020) · Antioxidants · doi:10.3390/antiox9080751 · Cited by 35
Kim, S., Saeidi, S., Cho, N., Kim, S. H., Lee, H., Han, W., Noh, D., & Surh, Y. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.11.047 · Cited by 35
NRF2 Regulation by Noncoding RNAs in Cancers: The Present Knowledge and the Way Forward
Fabrizio, F. P., Sparaneo, A., & Muscarella, L. A. (2020) · Cancers · doi:10.3390/cancers12123621 · Cited by 36
Brimson, J. M., Prasanth, M. I., Malar, D. S., Sharika, R., Sivamaruthi, B. S., Kesika, P., Chaiyasut, C., Tencomnao, T., & Prasansuklab, A. (2021) · Nutrients · doi:10.3390/nu13072162 · Cited by 38
Ballout, F., Lu, H., Chen, Z., Hu, T., Chen, L., Washington, M. K., El-Rifai, W. M., & Peng, D. (2022) · Antioxidants · doi:10.3390/antiox11101859 · Cited by 34
Mito-Nuclear Communication in Hepatocellular Carcinoma Metabolic Rewiring
Mello, T., Simeone, I., & Galli, A. (2019) · Cells · doi:10.3390/cells8050417 · Cited by 34
Inhibition of SGK1 confers vulnerability to redox dysregulation in cervical cancer
Wang, M., Xue, Y., Shen, L., Qin, P., Sang, X., Tao, Z., Yi, J., Wang, J., Liu, P.-X., & Cheng, H.-L. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101225 · Cited by 33
Apoptotic cell death induced by Z-Ligustilidein human ovarian cancer cells and role of NRF2
Lang, F., Qu, J., Yin, H., Li, L., Zhi, Y., Liu, Y., Fang, Z., & Hao, E. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.09.041 · Cited by 33
Antioxidant effects of sulforaphane in human HepG2 cells and immortalised hepatocytes
Liu, P., Wang, W., TANG, J. C. Y., Bowater, R. P., & Bao, Y. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.03.050 · Cited by 33
Yang, P., Xu, P., Cheng, C., Jiao, J., Wu, Y., Dong, S., Xie, J., & Zhu, X. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115516 · Cited by 32
The mechanistic insights of the antioxidant Keap1-Nrf2 pathway in oncogenesis: a deadly scenario
Mukherjee, A. G., & Gopalakrishnan, A. V. (2023) · Medical Oncology · doi:10.1007/s12032-023-02124-4 · Cited by 33
Li, Y.-J., Sun, L., Shi, Y., Wang, G., Wang, X., Dunn, S. E., Iorio, C., Screaton, R. A., & Spaner, D. (2017) · Leukemia · doi:10.1038/leu.2016.395 · Cited by 32
Importance of the Keap1-Nrf2 pathway in NSCLC: Is it a possible biomarker? (Review)
Rodríguez, R. B. (2018) · Biomedical Reports · doi:10.3892/br.2018.1143 · Cited by 32
Li, A., Shen, T., Wang, T., Zhou, M., Wang, B., Song, J., Zhang, P.-L., Wang, X., Ren, D., Lou, H., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.06.001 · Cited by 32
Role of the KEAP1-NRF2 Axis in Renal Cell Carcinoma
Clerici, S., & Boletta, A. (2020) · Cancers · doi:10.3390/cancers12113458 · Cited by 36
Xu, J., Zhu, K., Wang, Y., & Chen, J. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04447-7 · Cited by 32
Yan, L., Hu, H., Feng, L., Li, Z., Chunyan, Z., Zhang, J., Yin, X., & Li, B. (2024) · Medical Oncology · doi:10.1007/s12032-024-02483-6 · Cited by 33
The role of acetylation and deacetylation in cancer metabolism
Wang, C., & Ma, X. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70145 · Cited by 32
Modulatory Effects of Silymarin on Benzo[a]pyrene-Induced Hepatotoxicity
Jee, S.-C., Kim, M., & Sung, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072369 · Cited by 31
Liu, Y., Peng, B., Hsu, K., El‐Shazly, M., Shih, S., Lin, T. E., Kuo, F., Chou, Y.-C., Lin, H., & Lu, M. (2020) · Marine Drugs · doi:10.3390/md18080382 · Cited by 32
Redox sensitive miR-27a/b/Nrf2 signaling in Cr(VI)-induced carcinogenesis
Wang, L., Bayanbold, K., Zhao, L., Wang, Y.-F., Adamcakova‐Dodd, A., Thorne, P. S., Yang, H., Jiang, B., & Liu, L.-Z. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.151118 · Cited by 31
Negi, C. K., & Jena, G. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.10.026 · Cited by 30
Fabrizio, F. P., Sparaneo, A., Centra, F., Trombetta, D., Storlazzi, C. T., Graziano, P., Maiello, E., Fazio, V. M., & Muscarella, L. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112697 · Cited by 30
The Potential Role of Nrf2 Signaling in Leishmania Infection Outcomes
Vivarini, Á. D. C., & Lopes, U. G. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00453 · Cited by 30
Small Molecular Nrf2 Inhibitors as Chemosensitizers for Cancer Therapy
Lin, H., Qiao, Y., Yang, H., Nan, Q., Qu, W., Feng, F., Liu, W., Chen, Y., & Sun, H. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0285 · Cited by 30
Oxidative Stress in DNA Repeat Expansion Disorders: A Focus on NRF2 Signaling Involvement
Rosa, P. L., Petrillo, S., Bertini, E., & Piemonte, F. (2020) · Biomolecules · doi:10.3390/biom10050702 · Cited by 30
Progress of Photodynamic and RNAi Combination Therapy in Cancer Treatment
Li, K., Zhang, Y., Hussain, A., Weng, Y., & Huang, Y. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00765 · Cited by 30
Jiang, X., Zhou, X., Yu, X., Chen, X., Hu, X., Lu, J., Zhao, H., Cao, Q., Gu, Y., Yang, Y., et al. (2022) · Modern Pathology · doi:10.1038/s41379-022-01010-0 · Cited by 30
Chaperone-Mediated Autophagy in the Liver: Good or Bad?
Dash, S., Aydın, Y., & Moroz, K. (2019) · Cells · doi:10.3390/cells8111308 · Cited by 32
NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy
Sanghvi, V. R., Mohan, P., Singh, K., Cao, L., Berishaj, M., Wolfe, A. L., Schatz, J. H., Lailler, N., de Stanchina, E., Viale, A., et al. (2021) · Cancers · doi:10.3390/cancers13040639 · Cited by 27
Nakamura, H., Takada, K., Arihara, Y., Hayasaka, N., Murase, K., Iyama, S., Kobune, M., Miyanishi, K., & Kato, J. (2019) · Cancer Gene Therapy · doi:10.1038/s41417-018-0056-8 · Cited by 29
Stapled Peptides as Direct Inhibitors of Nrf2-sMAF Transcription Factors
Modi, R., McKee, N. W., Zhang, N., Alwali, A. A., Nelson, S. L., Lohar, A., Ostafe, R., Zhang, D. D., & Parkinson, E. I. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c02037 · Cited by 30
Sun, J., Zheng, Z., Chen, Q., Pan, Y., Lu, H., Zhang, H., Yu, Y., & Dai, Y. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s197409 · Cited by 29
Nadal, E., Palmero, R., & Muñoz‐Pinedo, C. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.08.005 · Cited by 29
Yang, H., Xiang, S., Kazi, A., & Sebti, S. M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011930 · Cited by 29
Tamir, T. Y., Bowman, B. M., Agajanian, M. J., Goldfarb, D., Schrank, T. P., Stohrer, T., Hale, A., Siesser, P. F., Weir, S., Murphy, R. M., et al. (2020) · Journal of Cell Science · doi:10.1242/jcs.241356 · Cited by 29
Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer Patients
Czogalla, B., Kahaly, M., Mayr, D. C., Schmoeckel, E., Niesler, B., Kolben, T., Burges, A., Mahner, S., Jeschke, U., & Trillsch, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010112 · Cited by 29
Ferroptosis-related signaling pathways in cancer drug resistance
Yang, Y., Yu, S., Liu, W., Zhuo, Y., Qu, C., & Zeng, Y. (2025) · Cancer Drug Resistance · doi:10.20517/cdr.2024.151 · Cited by 32
Gene regulatory effects of disease-associated variation in the NRF2 network
Lacher, S. E., & Slattery, M. G. (2016) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2016.09.001 · Cited by 27
Aydın, Y., Chedid, M., Chava, S. P., Williams, D. D., Liu, S., Hagedorn, C. H., Sumitran–Holgersson, S., Reiss, K., Moroz, K., Lu, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10087-6 · Cited by 28
RetractedIdentification of TC2N as a novel promising suppressor of PI3K-AKT signaling in breast cancer
Hao, X., Gao, L., Deng, X., Han, F., Chen, H., JIANG, X. H., Liu, W., Wang, D., Chen, J.-P., Cui, Z.-H., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1663-5 · Cited by 28
Beeraka, N. M., Bovilla, V. R., Doreswamy, S. H., Puttalingaiah, S., Srinivasan, A., & Madhunapantula, S. V. (2021) · Cancers · doi:10.3390/cancers13020281 · Cited by 28
The antioxidant response in Barrett's tumorigenesis: A double-edged sword
Peng, D., Zaika, A. I., Que, J., & El-Rifai, W. M. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101894 · Cited by 28
Emami, M. H., Sereshki, N., Malakoutikhah, Z., Dehkordi, S. A. E., Fahim, A., Mohammadzadeh, S., & Maghool, F. (2022) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2022.109266 · Cited by 30
Proteomic Analysis of Human Sputum for the Diagnosis of Lung Disorders: Where Are We Today?
D’Amato, M., Iadarola, P., & Viglio, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105692 · Cited by 28
Nishina, T., Deguchi, Y., Miura, R., Yamazaki, S., Shinkai, Y., Kojima, Y., Okumura, K., Kumagai, Y., & Nakano, H. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.744755 · Cited by 28
Chemopreventive Activities of Sulforaphane and Its Metabolites in Human Hepatoma HepG2 Cells
Liu, P., Wang, W., Zhou, Z., Smith, A. J. O., Bowater, R. P., Wormstone, I. M., Chen, Y., & Bao, Y. (2018) · Nutrients · doi:10.3390/nu10050585 · Cited by 27
Melanoma in the liver: Oxidative stress and the mechanisms of metastatic cell survival
Obrador, E., Salvador, R., López‐Blanch, R., Jihad-Jebbar, A., Alcácer, J., Benlloch, M., Pellicer, J. A., & Estrela, J. M. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.05.001 · Cited by 27
Catalase Overexpression Drives an Aggressive Phenotype in Glioblastoma
Flor, S., Oliva, C. R., Ali, M. Y., Coleman, K. L., Greenlee, J. D. W., Jones, K. A., Monga, V., & Griguer, C. E. (2021) · Antioxidants · doi:10.3390/antiox10121988 · Cited by 27
BACH1 Orchestrates Lung Cancer Metastasis
Anderson, N. M., & Simon, M. C. (2019) · Cell · doi:10.1016/j.cell.2019.06.020 · Cited by 27
Naturally-derived modulators of the Nrf2 pathway and their roles in the intervention of diseases
Wang, T., Liu, M., Li, X., Zhang, S., Gu, H., Wei, X., Wang, X., Xu, Z., & Shen, T. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.09.035 · Cited by 29
Ryu, D.-Y., Lee, J., & Kwak, M. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01298-z · Cited by 27
Changes in Microbial Community Composition Related to Sex and Colon Cancer by Nrf2 Knockout
Song, C., Kim, N., Nam, R. H., Choi, S. I., Yu, J. E., Nho, H., & Surh, Y. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.636808 · Cited by 26
Naked Mole-Rats: Resistant to Developing Cancer or Good at Avoiding It?
Hadi, F., Smith, E. S. J., & Khaled, W. T. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65943-1_14 · Cited by 26
The nexus between redox state and intermediary metabolism
Zoccarato, A., Nabeebaccus, A., Oexner, R. R., Santos, C. X. C., & Shah, A. M. (2021) · FEBS Journal · doi:10.1111/febs.16191 · Cited by 27
Metformin increases the radiosensitivity of non-small cell lung cancer cells by destabilizing NRF2
Sun, X., Dong, M., Gao, Y., Wang, Y., Du, L., Liu, Y., Wang, Q., Ji, K., He, N., Wang, J., et al. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114981 · Cited by 26
NFR2/ABC transporter axis in drug resistance of breast cancer cells
Sargazi, Z., Yazdani, Y., Tahavvori, A., Youshanlouei, H. R., Alivirdiloo, V., Beilankouhi, E. A. V., & Valilo, M. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08384-7 · Cited by 26
Metadata
- Authors
- Menegon, S., Columbano, A., & Giordano, S.
- Affiliations
- Candiolo Cancer Institute (IT)
- University of Cagliari (IT)
- Corresponding author
- Menegon, Silvia
- Columbano, Amedeo
- Giordano, Silvia
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 22
- Issue
- 7
- Pages
- 578-593
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W2417535489
- Cited by
- 633
- References
- 114
- Citations by year
- 2026: 28 · 2025: 43 · 2024: 64 · 2023: 60 · 2022: 74 · 2021: 75 · 2020: 69 · 2019: 72 · 2018: 73 · 2017: 57 · 2016: 16
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Trends in Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, cc-by-nc-nd)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- Funders
- Associazione Italiana per la Ricerca sul Cancro (15464, 15279, IG-15279)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Keywords
- Nrf2, Nrf2 signaling, oncogenic function, tumor suppressor, oxidative stress, chemoresistance, radioresistance (biology), Nrf2 inhibitors, therapeutic target, cancer
- MeSH terms
- Kelch-Like ECH-Associated Protein 1, Animals, Antineoplastic Agents, Humans, Mutation, Neoplasms, Signal Transduction, Gene Expression Regulation, Neoplastic, Oxidative Stress, MicroRNAs, Epigenesis, Genetic, NF-E2-Related Factor 2, Drug Discovery, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review